Pioneer in clinical pharmacology will be deeply missed
MMV mourns the loss of Professor Sir Colin Dollery
PDPs reduce investment risks and stretch limited budgets leading to 375 innovations targeting infectious diseases under development.
New report demonstrates how R&D partnerships serving neglected communities have developed dozens of life-saving innovations since 2010
SMC IMPACT aims to expand use of seasonal malaria chemoprevention in five African countries.
Republic of Korea grants USD 10 million to MMV-led consortium to protect children from malaria in the Sahel
Acceptance to review the paediatric dossier by the Australian drug regulator is an important and big step towards making this medicine available to the children that need it